A case of metachronous peripheral T-Cell non-Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin.
作者信息
Meconi Federico, Provenzano Ida, Nasso Daniela, Mariotti Benedetta, Pupo Livio, Secchi Roberto, Cerretti Raffaella, Lucia Anemona, Arcese William, Cantonetti Maria
机构信息
Department of Biomedicine and Prevention University Tor Vergata Rome Italy.
Anatomic Pathology Department of Biomedicine and Prevention University of Rome Tor Vergata Rome Italy.
出版信息
Clin Case Rep. 2020 May 5;8(8):1353-1356. doi: 10.1002/ccr3.2898. eCollection 2020 Aug.
Occasionally, non-Hodgkin lymphomas (NHL) occur simultaneously or subsequently to Hodgkin disease. We report on a case of a woman with Hodgkin lymphoma treated with ABVD, who developed 4 years later T-cell NHL with both nodal and extranodal involvement. Brentuximab vedotin could be an effective choice in treating metachronous T-cell NHL.
Zotero 插件